Canbiola, Inc. has Purchased Pure Health Products LLC and is Launching Pure Leaf Oil as its Consumer Brand

HICKSVILLE, NY, Jan. 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Canbiola, Inc. (OTCQB: CANB) has purchased Pure Health Products LLC and is launching Pure Leaf Oil as its consumer brand. 

Due to strong product demand,  is on the path toward significant revenue growth in additional segments of the CBD industry.  While the Canbiola brand is synonymous with Medical Offices and our Doctor affiliate program, the company has launched  targeting retail markets including c-stores, bodegas, and yes, even donut stores and bakeries through its network of distributors. Pure Leaf Oil is also expected to be sold through various leading online e-commerce platforms at very aggressive prices.

. has recently completed the acquisition of Pure Health Products LLC including the laboratory and production facility located outside Seattle Washington.  The facility is a full-on development laboratory and a fully integrated production facility whereby all formulations, processes, and materials are vertically integrated in the production process.  There are no third-party vendors and the company controls the process at each step of processing to insure 100% quality control and product purity.  Additionally, all the automated processing and packaging equipment are wholly owned, and the company has no debt.

According to Marco Alfonsi, CEO of ., “We believe the timing is right for the roll-out of the new Pure Leaf Oil CBD brands and have already aligned with some substantial distributors representing thousands of retail stores to commence distribution.”   Mr. Alfonsi continued, “The new Pure Leaf Oil products will mirror the Canbiola product line offering in product strength and efficacy and provide better access to patients seeking over-the-counter pain relief and wellness products containing CBD with none of the marijuana THC psychoactive side effects.”  Lastly, Mr. Alfonsi added, “To have a seasoned professional as Mr. Pasquale (Pat) Ferro head up the Pure Health Products subsidiary as President speaks to the quality of the entire Canbiola staff and professional team.  Pat is a friend, a strong manager with a proven track record, and is heading up the future product development efforts for the company.”

Mr. Pasquale (Pat) Ferro, newly named President of Pure Health Products, says, “It is a once in a lifetime opportunity to be aligned with a visionary company such as Canbiola, and we at Pure Health Products believe the synergies between our companies will paint a long-term productive and profitable path for the future for all of our shareholders.” Pat concludes with, “We are committed to produce the highest quality products, with the greatest contribution to better health and wellness for our customers and know that we have the personnel, processes, and technology in place for a long-term CBD program of new and exciting products.”

About Canbiola, Inc.

Canbiola, Inc. is a public company trading under symbol CANB.

Canbiola, Inc. is a US Company embarking in the sale of a variety of Cannabidiol (CBD) based products. Canbiola has developed its own line of proprietary products as well as seeking synergistic value through acquisitions in the CBD and the medical cannabis industry. Cannabis is currently federally illegal and has legalized for medical purposes in some form in a limited number of states, but pure CBD products are legal in all 50 states. The company has already launched several products found at .

Forward-looking statements and risks and uncertainties discussed in this letter contain forward-looking statements. The words "anticipate," "believe," "estimate," "may," "intend," "expect," and similar expressions identify such forward-looking statements. Expected, actual results, performance, or achievements could differ materially from those contemplated, expressed, or implied by the forward-looking statements contained herein. Forward-looking statements are subject to a number of risks and uncertainties, including but not limited to, risks and uncertainties associated with, among other things, the impact of economic, competitive, and other factors affecting our operations, markets, products, and performance. The matters discussed herein should not be construed in any way, shape or manner of our future financial condition or stock price.